Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Chapel Hill, NC
SEC filing record 1 source field available
Fiscal year end
31 December
TENAX THERAPEUTICS, INC. has filed 987 SEC EDGAR filings since 02 Aug 1996

SEC filing history

Showing 351-375 of 819 matching filings.

Per page
25
Current page
15
4

FORM 4

Filing date
15 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Jun 2021
Reporting date
11 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
15 Jun 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
15 Jun 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

FORM 8-K

Filing date
11 Jun 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

FORM 8-K

Filing date
01 Jun 2021
Reporting date
28 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34600

QUARTERLY REPORT

Filing date
17 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
DEF 14A File 001-34600

DEF 14A

Filing date
30 Apr 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34600

PRE 14A

Filing date
20 Apr 2021
Reporting date
10 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-34600

FORM 10-K/A

Filing date
16 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
07 Apr 2021
Reporting date
02 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-34600

ANNUAL REPORT

Filing date
31 Mar 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
8-K/A File 001-34600

AMENDED CURRENT REPORT

Filing date
30 Mar 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
29 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
02 Mar 2021
Reporting date
25 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
01 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-58467

SC 13G/A filing

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-58467

TENX 13GA

Filing date
11 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
27 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
19 Jan 2021
Reporting date
15 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2021
Reporting date
05 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
18 Nov 2020
Reporting date
18 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .